A Multicenter, Randomized, Controlled Trial of Combination Therapy for HBeAg Positive Chronic Hepatitis B: Comparing Thymosin Alpha 1 and Pegylated Interferon-alpha2a With Pegylated Interferon-alpha2a Alone.
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2012
At a glance
- Drugs Peginterferon alfa-2a; Thymalfasin
- Indications Hepatitis B
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Jul 2011 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 20 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History